Novel transcript, antisense to zinc finger protein 536 (ENSG00000267223)

This molecule is an RNA transcript classified as antisense to the zinc finger protein 536 (ZNF536) gene. Antisense transcription can regulate the expression, stability, and processing of the sense (protein-coding) transcript by altering chromatin structure and transcript dynamics near the promoter region[3][4]. While antisense RNAs are widespread and play roles in fine-tuning gene expression across eukaryotic genomes, including humans, this specific transcript is not known to encode a protein, function as a receptor, or act as a drug target in therapeutic contexts[1][3][4]. Its primary significance is likely regulatory, possibly by modulating ZNF536 expression, which is itself a transcription factor involved in neuronal differentiation[2][5]. Key points: - The molecule is a non-coding regulatory transcript (antisense RNA). - Not classified as a classic drug target or clinically actionable gene. - Its main function is presumed gene regulation at the chromatin/transcriptional level. - Not linked to diseases, drug interactions, or biomarker applications. - There is no evidence for use as a safety concern or therapeutic challenge. This transcript should not be considered a molecular target for standard drug discovery or pharmacological profiling.

Other names

ENSG00000267223Novel transcript antisense to ZNF536Antisense RNA to ZNF536

null